Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates (REVAMP)

May 3, 2013 updated by: June Tangney, George Mason University

Pilot Evaluation of the Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates

This is a pilot study to examine the acceptability and effectiveness of the Re-Entry Values and Mindfulness Program (REVAMP), a group intervention for jail inmates. It is hypothesized that REVAMP will reduce post-release recidivism, substance abuse, and HIV risk behavior.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Phase 2
  • Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Virginia
      • Fairfax, Virginia, United States, 22030
        • Fairfax County Adult Detention Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Must be 18 years or older
  • Must be male
  • Must be currently incarcerated jail inmate
  • Must be sentenced
  • Sentence must be short enough to serve out sentence at the Adult Detention Center
  • Release date must follow projected final session of treatment
  • Must speak, read, and write in English with sufficient proficiency to use workbook and participate in group sessions
  • Must be assigned to the jail's "general population"

Exclusion Criteria:

  • Actively psychotic
  • Assigned "keep separate" from other group members

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Values-based mindfulness group
The Re-entry values and mindfulness program (REVAMP) is an 8 session group intervention designed for jail inmates nearing release into the community
Behavioral: REVAMP
The Re-entry values and mindfulness program (REVAMP) is an 8 session group intervention designed for jail inmates nearing release into the community
Other: Treatment as usual
has access to standard jail interventions and programs
Behavioral: TAU
have access to standard jail programs and services

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Recidivism - Self Report of undetected crimes
Time Frame: 3 months post-release
3 months post-release
Recidivism - Self Report of Arrests
Time Frame: 3 months post-release
3 months post-release
Recidivism - Official Records of arrests
Time Frame: 3 months post-release
3 months post-release
Substance Dependence symptoms - Texas Christian University (TCU) measure
Time Frame: 3 months post-release
3 months post-release
HIV Risk Behavior - Sex and Intravenous Drug Use (IDU) - TCU
Time Frame: 3 months post-release
3 months post-release
Acceptability - number of participants who report finding the treatment helpful and number who would recommend the treatment to a friend
Time Frame: 1 week post-treatment
1 week post-treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
Mindfulness - Self report using Mindfulness Inventory: Nine Dimensions (MI:ND)
Time Frame: 1 week post-treatment and 3 months post-release
1 week post-treatment and 3 months post-release
Self Control - Self report using Brief Self control Scale (BSC)
Time Frame: post-treatment and 3 months post-release
post-treatment and 3 months post-release
Self-Compassion - Self report using Neff's scale
Time Frame: 1 week post-treatment and 3 months post-release
1 week post-treatment and 3 months post-release
Distress-Driven Impulsivity - Behavioral measure using Balloon Analog Reaction Test (BART) preceded by mirror tracing task
Time Frame: 1 week post-treatment
1 week post-treatment
Psychological Symptoms - Self report using Personality Assessment Inventory
Time Frame: 1 week post-treatment and 3 months post-release
1 week post-treatment and 3 months post-release

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

George Mason University

Investigators

  • Principal Investigator: June P Tangney, PhD, George Mason University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2011

Primary Completion (Anticipated)

June 1, 2013

Study Completion (Anticipated)

June 1, 2013

Study Registration Dates

First Submitted

June 17, 2011

First Submitted That Met QC Criteria

June 22, 2011

First Posted (Estimate)

June 23, 2011

Study Record Updates

Last Update Posted (Estimate)

May 7, 2013

Last Update Submitted That Met QC Criteria

May 3, 2013

Last Verified

May 1, 2013

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CCT-01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe